Summary of Discussion: Improving Vaccination for Immunocompromised Populations

This RSA board meeting brought together clinicians, researchers, policymakers, patient advocates, and industry representatives to address barriers to vaccination for immunocompromised (IC) individuals. The meeting’s objectives included defining “immunocompromised,” identifying systemic barriers to vaccine access, and proposing strategies to optimize immunization schedules. Speakers and attendees called for a unified patients-researcher-clinicians-policy maker partnership to lead efforts of addressing longstanding inequities in vaccination access for immunocompromised Canadians. See the full summary for more.